Table 4 Organ absorbed doses for ICRP 133 standard man and standard woman
Target organs | Absorbed dose (μGy/MBq) | |||||
|---|---|---|---|---|---|---|
Male (N = 2) | Female (N = 3) | |||||
Lungs | 42.14 | ± | 7.16 | 40.93 | ± | 3.11 |
Stomach wall | 17.05 | ± | 2.97 | 17.89 | ± | 4.18 |
Colon | 8.74 | ± | 0.17 | 9.16 | ± | 1.11 |
Red marrow | 14.68 | ± | 2.67 | 20.03 | ± | 2.89 |
Breast | 6.95 | ± | 0.56 | 6.71 | ± | 0.74 |
Ovaries | 11.27 | ± | 1.24 | |||
Testes | 3.75 | ± | 0.07 | |||
Thyroid | 16.95 | ± | 2.11 | 38.60 | ± | 28.72 |
Oesophagus | 13.49 | ± | 1.89 | 13.74 | ± | 1.63 |
Urinary bladder wall | 23.23 | ± | 6.37 | 32.63 | ± | 4.15 |
Liver | 52.91 | ± | 1.46 | 61.66 | ± | 13.61 |
Endosteum | 7.63 | ± | 1.20 | 10.56 | ± | 1.37 |
Skin | 3.43 | ± | 0.13 | 4.00 | ± | 0.66 |
Brain | 27.35 | ± | 5.18 | 33.17 | ± | 0.44 |
Salivary glands | 4.02 | ± | 0.47 | 5.41 | ± | 0.46 |
Adrenals | 17.99 | ± | 0.18 | 22.34 | ± | 3.84 |
Extrathoracic tissue | 5.59 | ± | 0.75 | 6.66 | ± | 0.63 |
Gallbladder wall | 27.27 | ± | 0.70 | 29.44 | ± | 5.98 |
Heart wall | 43.94 | ± | 12.88 | 39.33 | ± | 5.06 |
Kidneys | 27.24 | ± | 0.27 | 31.01 | ± | 1.88 |
Lymphatic nodes | 9.77 | ± | 0.45 | 10.45 | ± | 1.27 |
Muscle | 7.91 | ± | 0.10 | 11.54 | ± | 0.77 |
Oral mucosa | 4.08 | ± | 0.50 | 5.12 | ± | 0.48 |
Pancreas | 15.44 | ± | 0.13 | 14.90 | ± | 2.54 |
Prostate | 11.19 | ± | 2.08 | |||
Small intestine | 9.82 | ± | 0.74 | 12.03 | ± | 1.59 |
Spleen | 36.44 | ± | 7.41 | 39.69 | ± | 8.29 |
Thymus | 9.16 | ± | 1.51 | 10.08 | ± | 0.89 |
Uterus/cervix | 15.72 | ± | 1.80 | |||